These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2085408)

  • 1. Mosaicism induced by gene insertion as a means of improving chemotherapeutic selectivity.
    Moolten FL
    Crit Rev Immunol; 1990; 10(3):203-33. PubMed ID: 2085408
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy.
    Skipper HE; Simpson-Herren L
    Important Adv Oncol; 1985; ():63-77. PubMed ID: 3870935
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy utilizing drug resistance genes: a review.
    Banerjee D; Zhao SC; Li MX; Schweitzer BI; Mineishi S; Bertino JR
    Stem Cells; 1994 Jul; 12(4):378-85. PubMed ID: 7951004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular maturation and oncogene expression during drug-induced differentiation in vitro: a brief review.
    Biedler JL; Spengler BA; Ross RA
    Prog Clin Biol Res; 1990; 354A():287-312. PubMed ID: 2247493
    [No Abstract]   [Full Text] [Related]  

  • 5. [Perspectives on modulation of chemoresistance of malignant diseases].
    Allerödder HP; Ukena D; Sybrecht GW
    Pneumologie; 1993 Sep; 47(9):513-7. PubMed ID: 7901849
    [No Abstract]   [Full Text] [Related]  

  • 6. Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence.
    Griswold DP
    Cancer Treat Rep; 1986 Jan; 70(1):81-6. PubMed ID: 3943116
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical implications of tumor-cell heterogeneity.
    Schnipper L
    N Engl J Med; 1986 May; 314(22):1423-31. PubMed ID: 3517651
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene amplification, drug resistance, and cancer.
    Schimke RT
    Cancer Res; 1984 May; 44(5):1735-42. PubMed ID: 6713376
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple drug resistance in cancer therapy.
    Schneider E; Cowan KH
    Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clonogenic cells in human tumors and the sensitivity to chemotherapy].
    Potapov SL; Korman DB
    Eksp Onkol; 1986; 8(1):7-12. PubMed ID: 3512239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell gene therapy with drug resistance genes: an update.
    Budak-Alpdogan T; Banerjee D; Bertino JR
    Cancer Gene Ther; 2005 Nov; 12(11):849-63. PubMed ID: 16037821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative to the magic bullet paradigm for specific cancer therapy.
    Moolten FL
    Med Hypotheses; 1987 Sep; 24(1):43-51. PubMed ID: 3670131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells: a step toward the cure.
    Boman BM; Wicha MS
    J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
    [No Abstract]   [Full Text] [Related]  

  • 14. Parvoviral vectors for the gene therapy of cancer.
    Shaughnessy E; Lu D; Chatterjee S; Wong KK
    Semin Oncol; 1996 Feb; 23(1):159-71. PubMed ID: 8607026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines.
    Bonovich M; Olive M; Reed E; O'Connell B; Vinson C
    Cancer Gene Ther; 2002 Jan; 9(1):62-70. PubMed ID: 11916245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of antitumor (antimetastatic) efficacy of cytotoxic agents.
    Milas L; Tofilon PJ; Brock WA
    Prog Clin Biol Res; 1986; 212():305-21. PubMed ID: 3520579
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular interrelationships in multidrug resistance (review).
    Kellen JA
    Anticancer Res; 1994; 14(2A):433-5. PubMed ID: 8017843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemotherapy using suicide genes.
    Singhal S; Kaiser LR
    Surg Oncol Clin N Am; 1998 Jul; 7(3):505-36. PubMed ID: 9624215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
    Latham JP; Searle PF; Mautner V; James ND
    Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.